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ABSTRACT: Several studies have been carried out to
evaluate the alterations in mitochondrial functions of
diabetic rats. However, some of the results reported are
controversial, since experimental conditions, such as
aging, and/or strain of animals used were different. The
purpose of this study was to evaluate the metabolic
changes in liver mitochondria, both in the presence
of severe hyperglycaemia (STZ-treated rats) and mild
hyperglycaemia (Goto-Kakizaki (GK) rats). Moreover,
metabolic alterations were evaluated both at initial and
at advanced states of the disease.
We observed that both models of type 1 and type 2
diabetes presented alterations on respiratory chain ac-
tivity. Because of continual severe hyperglycaemia, 9
weeks after the induction of diabetes, the respiratory
function declined in STZ-treated rats, as observed by
membrane potential and respiratory ratios (RCR, P/O,
and FCCP-stimulated respiration) assessment. In con-
trast, GK rats of 6 months age presented increased res-
piratory ratios.
To localize which respiratory complexes are af-
fected by diabetes, enzymatic respiratory chain activ-
ities were evaluated. We observed that succinate de-
hydrogenase and cytochrome c oxidase activities were
significantly augmented both in STZ-treated rats and
GK rats of 6 months age. Moreover, H+-ATPase activ-
ity was also significantly increased in STZ-treated rats
with 3 weeks of diabetes and in GK rats of 6 months age
as compared to controls. Therefore, these results clearly
suggest that both animal models of diabetes present
some metabolic adjustments in order to circumvent the
deleterious effects promoted by the high glucose lev-
els typical of the disease. C© 2003 Wiley Periodicals, Inc.
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INTRODUCTION
Diabetes mellitus is a common degenerative dis-
ease and one of the leading causes of morbidity and
mortality in developed countries. Diabetes is a major
cause of serious micro-(rethinopathy, nephropathy, and
neuropathy) and macrovascular diseases (cardiovascu-
lar diseases and nontraumatic lower extremity ampu-
tations), affecting, therefore, nearly every organ in the
body.
Clinically, diabetes mellitus is an heterogeneous
disease, with a common phenotype of impaired glucose
tolerance and, depending on the basis of the manage-
ment required to control glucose homeostasis, it can be
divided in type 1 and type 2 diabetes.
Type 1 diabetes occurs mainly in childhood and
puberty and is characterized by an absolute insulin de-
ficiency, requiring daily insulin replacement therapy,
in addition to diet and physical activity. Type 2 dia-
betes usually develops in adults over age 40, accounts
for 90–95% of all diagnosed cases and is characterized
by insulin resistance and/or inadequate compensatory
insulin secretion response [1].
To understand the physiological and pathological
changes of this complex disease, animal models of dia-
betes are important research tools, since animal studies
allow for tight control over experimental conditions,
which is almost impossible to achieve in human popu-
lations [2,3].
In the present study, we used STZ-induced rats
as type 1 and Goto-Kakizaki (GK) rats as type 2 dia-
betes mellitus models. STZ-induced diabetic rats, com-
monly used as an animal model of type 1 diabetes mel-
litus, are obtained after selective destruction of -cell
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by streptozotocin (STZ), a broad spectrum antibiotic,
with diabetogenic effects. STZ-injected rats present
many characteristics seen in insulin-dependent diabetic
human patients: hypoinsulinemia, hyperglycaemia, ke-
tonuria, and hyperlipidaemia [2]. Therefore, this model
is of great use to evaluate the changes promoted by un-
controlled type 1 diabetes.
Goto-Kakizaki (GK) rats are currently used as an
animal model of type 2 diabetes. This animal is a
nonobese, spontaneously diabetic rat [3], produced by
selective breeding of Wistar rats, using glucose intoler-
ance as selection index [4–7]. GK rats exhibit a moder-
ate but stable fasting hyperglycemia (until the age of 6
months), evident from 6 weeks of age, which does not
progress to a ketotic state. Furthermore, GK rat is one
of the best-characterized animal models of spontaneous
non-obese type 2 diabetes mellitus, since it exhibits sim-
ilar metabolic, hormonal, and vascular disorders to the
human disease [3]. Therefore, in the initial stages of
diabetes, GK rats do not exhibit severe complications
associated with the disease, being an important model
to study the initial events of diabetes.
While insulin release decreases in diabetes,
glucagon release increases, promoting an enlarged
glycogen degradation rate. So, liver cells are first sur-
rounded by higher glucose levels compared to other
body cells. These permanent high glucose levels can
promote nonenzymatic protein and lipid glycosylation
and lead to energy metabolism alterations. Moreover,
alterations in adenosine triphosphate (ATP) generation
also affect glycolysis ratio, decreasing glucose utiliza-
tion, since glucokinase (and hexokinase) activity de-
pends on the intracellular pool of ATP [8,9]. Therefore,
in the present paper, we compare the possible alter-
ations in liver mitochondrial respiratory system in STZ
and GK rats, during the progression of diabetes, with
the purpose of evaluating the metabolic modifications
in liver mitochondria.
MATERIALS AND METHODS
Materials
Streptozotocin [2-deoxy-2-(3-methyl-3-nitrosurea)
1-D-glucopyranose] was obtained from Sigma, St.
Louis, MO, USA, and prepared prior to use in 100 mM
citrate, pH 4.5. All other reagents and chemicals used
were of the highest grade of purity commercially
available.
Animals
Male spontaneously diabetic GK rats with 3 or
6 months of age were used. These rats were ob-
tained from a local breeding colony (Animal Research
Center Laboratory, University Hospitals, Coimbra), es-
tablished in 1995 with breeding couples from the colony
at the Tohoku University School of Medicine (Sendai,
Japan; courtesy of Dr. K. Susuki). Control animals were
nondiabetic male Wistar rats of similar age.
Animals were kept under controlled light (12 h
day/night cycle), temperature (22–24◦C), and humid-
ity (50–60%) conditions and with free access to pow-
dered rodent chow (diet URF1, Charles Rivers, France)
and water (pH 5.5), except in the fasting periods. In this
study the “Principles of Laboratory Animal Care” (NIH
publication 83-25, revised 1985) were followed. During
this period, weights were measured and glycaemia was
determined from the tail vein using a commercial glu-
cometer (Glucometer-Elite, Bayer).
Induction and Characterization
of STZ-Induced Diabetes
Male Wistar rats of about 200 g (3 months) were
divided randomly into two groups of 10 animals each.
To induce diabetes, one group was injected intraperi-
toneally, with a single injection of streptozotocin (STZ,
50 mg/kg), after a 16 h fasting period. The volume used
was always 0.5 mL/200 g body weight. Control animals
were injected with the same volume of citrate solution.
In the following 24 h, animals were fed with glycolated
serum in order to avoid hypoglycemia resulting from
massive destruction of -cells and release of intracellu-
lar insulin associated with STZ treatment [2]. Animals
were kept 3 or 9 weeks before the experiments. During
this period, weights were measured and glycemia was
determined from the tail vein using a commercial glu-
cometer (Glucometer-Elite, Bayer). Values were taken
in fasting conditions just before STZ administration and
in nonfasting conditions in the weeks after. If feeding
blood glucose in the tail vein exceeded 250 mg/dL, an-
imals were used as diabetic.
Glycemia and HbA1C Evaluation
Blood glucose concentration was determined im-
mediately after sacrifice (Glucometer-Elite, Bayer). The
glycated hemoglobin (HbA1C) values were determined
in blood collected at the time of animals’ death through
ionic exchange chromatography (Abbott Imx Glicohe-
moglobin, Abbott Laboratories, Portugal).
Preparation of Mitochondria
Mitochondria were isolated from the liver of nor-
mal and diabetic rats, maintained ad libitum for at least
12 h before being sacrificed, according to a previously
established method [10], with slight modifications.
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Homogenization medium contained 250 mM su-
crose, 5 mM HEPES (pH 7.4), 0.2 mM EGTA, 0.1 mM
EDTA, and 0.1% defatted BSA (bovine serum albumin).
EDTA, EGTA, and defatted BSA were omitted from the
final washing medium and adjusted to pH 7.2. The mi-
tochondrial pellet was washed twice, suspended in the
washing medium, and immediately used. Protein was
determined by the Biuret method, using BSA as a stan-
dard [11].
Membrane Potential () Measurements
The mitochondrial transmembrane potential was
estimated by calculating transmembrane distribution
of TPP+ (tetraphenylphosphonium ion) with a TPP+ se-
lective electrode prepared, as previously reported [12],
using a calomel electrode as a reference. TPP+ uptake
was measured from the decrease in TPP+ concentration
in the medium. The potential difference between the se-
lective and the reference electrodes was measured with
an electrometer and continuously recorded. A matrix
volume of 1.1 L/mg was assumed and valinomycin
was used to calibrate the baseline. Reactions were car-
ried out at 25◦C in 1 mL of the reaction media (130 mM
sucrose, 50 mM KCl, 5 mM MgCl2, 5 mM KH2PO4,
5 mM HEPES, pH 7.2), supplemented with 3 M TPP+,
2 M rotenone, 1 mg mitochondria, and 5 mM succi-
nate. To induce state 3 (ADP), 200 nmol ADP were
used. Oxygen consumption was measured simultane-
ously, as described below.
Mitochondrial Respiration
Oxygen consumption of isolated mitochondria was
determined polarographically at 25◦C with a Clark
oxygen electrode, connected to a suitable recorder in
a closed chamber with magnetic stirring. Mitochon-
dria (1 mg) and respiratory substrate (succinate) and
rotenone (2 M) were added to the standard reaction
medium (1 mL). To induce state 3, 200 nmol ADP
were used. The respiratory control ratio (RCR) and
ADP/O ratios were calculated according to Chance and
Williams [13]. FCCP-uncoupled respiration was per-
formed by adding 1 M of FCCP (carbonyl cyanide
p-trifluoromethoxyphenylhydrazone) to mitochondria
energized with succinate.
Enzymatic Activities
NADH:Q oxidoreductase (Complex I) activity was
evaluated spectrophotometrically at 25◦C by observ-
ing the NADH absorbance decrease at 340 nm, as pre-
viously described [14]. The assays were carried out at
25◦C in 1 mL of the standard reaction medium supple-
mented with 60 M decylubiquinone, 0.1 g antimycin
A, 1 mM KCN, and 0.5 mg protein of broken mitochon-
dria, with three cycles of freezing and thawing. The
reaction was initiated with 100 M NADH. Since only
the oxidation of NADH sensitive to rotenone inhibi-
tion leads to ATP synthesis, 2 min after the addition of
NADH, 2 M rotenone was added. The activity of the
enzyme was determined as the difference of absorbance
in the absence and in the presence of rotenone. Succi-
nate dehydrogenase (Complex II) activity was determined
polarographically [15] at 25◦C in 1 mL of the standard
reaction medium supplemented with 5 mM succinate,
2 M rotenone, 0.1 g antimycin A, 1 mM KCN, and
0.5 mg protein of broken mitochondria. The reaction
was initiated with 1 mM PMS (phenazyne methasul-
phate), used as an artificial electron acceptor. Succinate
cytochrome c reductase (Complexes II-III) activity was
evaluated spectrophotometrically [16], by following the
reduction of oxidized cytochrome c by the increase in
absorbance at 550 nm. The reaction was initiated by the
addition of 5 mM succinate to 2.0 mL of the standard
reaction medium supplemented with 2 M rotenone,
1 mM KCN, 60 M cytochrome c, and 0.3 mg protein
of broken mitochondria. Cytochrome c oxidase (Complex
IV) activity was determined polarographically [17], at
25◦C in 1 mL of the standard reaction medium supple-
mented with 2 M rotenone, 0.1 g antimycin A, 10 M
cytochrome c, and 0.5 mg protein of broken mitochon-
dria. The reaction was initiated by the addition of 5 mM
ascorbate plus 0.25 mM TMPD (N,N,N’,N’-tetramethyl-
p-phenylenediamide). F1-ATPase (Complex V) activity
was determined by following the amount of protons re-
leased upon ATP hydrolysis, through a potentiometric
method, as described previously [18,19]. The reaction
was carried out at 25◦C in 2 mL of reaction medium
(130 mM sucrose, 50 mM KCl, 5 mM MgCl2, 0.5 mM
HEPES, 2 M rotenone, pH 7.2).
Statistical Analyses
The results are presented as mean ± SEM of the
number of experiments indicated and statistical signifi-
cance between diabetic rats and their control group was
determined using unpaired Student’s t test. Multiple
comparison were performed using one-way ANOVA,
using Student–Newman–Keuls test. For both analysis
p < 0.05 was considered significant.
RESULTS
Characterization of Animals
Blood glucose levels, determined immediately af-
ter each animal’s death, were significantly higher in
diabetic rats when compared to controls (Table 1).
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TABLE 1. Characterization of Animals
Condition Weight (% of Initial Weight) Glycaemia (mg/dL) HbA1C
3 Weeks
Wistar 123.6 ± 10.68 (n = 6) 115.1 ± 4.48 (n = 6) 5.23 ± 0.209 (n = 6)
STZ 89.7 ± 3.71 (n = 6)∗∗∗ 409.3 ± 17.92 (n = 6)∗∗∗,‡†† 10.25 ± 0.429 (n = 6)∗∗∗,‡,††
9 Weeks
Wistar 190.5 ± 9.00 (n = 6)¶ 97.3 ± 5.49 (n = 6) 5.84 ± 0.472 (n = 6)
STZ 87.8 ± 5.61 (n = 6)∗∗∗∗, 468.6 ± 15.56 (n = 6)∗∗∗,†† 11.71 ± 0.391 (n = 6)∗∗∗,††
3 Months
Wistar 100.0 ± 3.69 (n = 8) 101.3 ± 5.04 (n = 8) 5.04 ± 0.115 (n = 6)
GK 81.3 ± 1.20 (n = 8) 141.2 ± 9.38 (n = 8)∗,‡‡‡,† 7.32 ± 0.670 (n = 6)∗,‡‡
6 Months
Wistar 173.6 ± 4.30 (n = 9) 85.7 ± 5.00 (n = 9) 5.43 ± 0.327 (n = 6)
GK 112.8 ± 1.49 (n = 9) 162.0 ± 28.58 (n = 9)∗,‡‡ 8.46 ± 0.889 (n = 6)∗∗,‡‡
Values are given as mean ± SEM of the number of independent experiments indicated. Initial weight was considered the weight at the time of injection with STZ
or vehicle, in STZ-treated rats and its controls, or the mean weight of Wistar rats of 3 months age, in GK rats, and control group of 6 months age. Blood glucose
concentration was determined immediately after animals sacrifice using a commercial glucometer (Glucometer-Elite, Bayer). The glycated hemoglobin (HbA1C)
values were determined at the time of animals’ death through ionic exchange chromatography (Abbott Imx Glicohemoglobin, Abbott Laboratories, Portugal).
∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 compared to controls; † p < 0.05, †† p < 0.01 compared to GK (6 months); ‡ p < 0.05, ‡‡ p < 0.01, ‡‡‡ p < 0.001,
compared to STZ (9 weeks); ¶ p < 0.0001, compared to Wistar (3 months/3 weeks).
However, GK rats presented mild hyperglycaemias
(120–210 mg/dL), while STZ-treated rats presented se-
vere hyperglycaemias (>380 mg/dL). To estimate the
severity of diabetes, glycated hemoglobin (HbA1c) was
also evaluated. HbA1c is a very useful parameter to
evaluate the severity of diabetes, since it indicates the
average blood glucose levels 2–3 months prior to the
analysis. The determined levels of HbA1c (see Table 1)
confirm that in diabetic rats blood glucose was signif-
icantly increased and these levels in STZ-treated rats
were also significantly augmented as compared to GK
rats. The weight was also determined and results are
presented as percentage of initial weight, in order to
exclude inaccuracies due to initial body weight varia-
tions. We observed that STZ-treated rats lost weight af-
ter treatment with this diabetogenic drug, while control
TABLE 2. Effect of Diabetes on Respiratory Indexes
FCCP-Stimulated Respiration
Condition RCR ADP/O (nmol ADP/nmol O) (nmol O/mg protein/min)
3 Weeks
Wistar 3.28 ± 0.119 (n = 6) 1.73 ± 0.074 (n = 6) 239.2 ± 13.09 (n = 5)
STZ 3.78 ± 0.236 (n = 6)∗,‡‡‡,† 1.97 ± 0.061 (n = 6)∗ 293.5 ± 10.43 (n = 5)∗,‡‡‡
9 Weeks
Wistar 3.36 ± 0.244 (n = 6) 1.68 ± 0.069 (n = 6) 224.2 ± 12.10 (n = 5)
STZ 3.02 ± 0.122 (n = 6)‡‡‡ 1.74 ± 0.074 (n = 6) 196.4 ± 5.17 (n = 5)
3 Months
Wistar 3.21 ± 0.084 (n = 8) 1.72 ± 0.044 (n = 8) 259.4 ± 12.10 (n = 6)
GK 3.67 ± 0.218 (n = 8)∗,‡‡‡,† 1.88 ± 0.033 (n = 8)∗∗ 287.4 ± 7.77 (n = 6)∗,‡‡‡
6 Months
Wistar 3.12 ± 0.298 (n = 9) 1.69 ± 0.021 (n = 9) 250.8 ± 12.62 (n = 7)
GK 4.59 ± 0.124 (n = 9)∗∗∗,††† 1.94 ± 0.065 (n = 9)∗∗∗ 285.4 ± 3.87 (n = 7)∗,‡‡‡
Mitochondria (1 mg protein) were incubated in 1 mL of the respiratory standard medium. RCR and ADP/O were determined accordingly to Chance and Williams
[13]. FCCP-stimulated respiration was determined upon the addition of 1.5 M of FCCP to mitochondria energized with succinate. Values are given as mean ± SEM
of the number of independent experiments indicated, performed with at least three different mitochondrial preparations.
∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 compared to controls; † p < 0.05, ††† p < 0.001, compared to GK (6 months); ‡ p < 0.05, ‡‡‡ p < 0.001, compared to STZ
(9 weeks).
groups gained weight as usual. We also observed that
GK rats gained weight slowly than did their control
groups.
Studies of Respiratory Indexes
Respiratory indexes (RCR: respiratory control ratio,
ADP/O, and FCCP-stimulated respiration) were eval-
uated in GK, STZ-induced diabetic rats, and respective
controls in the presence of succinate as respiratory sub-
strate (Table 2).
We observed that RCR ratio was significantly in-
creased both in GK rats of 3 and 6 months age and
in STZ-treated rats, 3 weeks after the treatment, when
compared to controls while STZ-treated rats 9 weeks af-
ter the treatment showed a slightly decrease. Moreover,
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we found that ADP/O ratio was also significantly in-
creased both in GK rats of 3 and 6 months and in
STZ-treated rats 3 weeks following the treatment when
compared to their respective control group, whereas 9
weeks after the treatment, ADP/O ratio in STZ-treated
rats decrease to the same level of non-diabetic rats. Ad-
ditionally, we observed that FCCP-stimulated respira-
tion is also considerably enhanced in GK rats of 3 and 6
months and in STZ-treated rats 3 weeks after the injec-
tion of STZ, compared to controls. However, 9 weeks
after the treatment, STZ-treated rats presented a de-
creased stimulated respiration, indicating an inhibition
of its respiratory chain activity.
These results were confirmed by membrane po-
tential evaluation (Table 3). In fact, membrane poten-
tial developed after addition of succinate is signifi-
cantly enlarged in GK rats (with 3 and 6 months of
age) and in STZ-treated rats after 3 weeks of treat-
ment, suggesting that their respiratory chain is stim-
ulated. Furthermore, repolarization rate, an evalua-
tion of phosphorylation activity, is also increased in
these diabetic rats, indicating that the phosphoryla-
tive system is also enhanced as compared to con-
trols. However, 9 weeks after the development of se-
vere diabetes, in STZ-treated rats the respiratory chain
and the phosphorylative system activity decreased
to the same level as that of the non-diabetic rats.
Furthermore, lag phase, another indicative parameter
of phosphorylative system activity, is inversely pro-
portional to repolarization rate, corroborating these
results.
No significant differences between diabetic and
respective controls were observed in the membrane
TABLE 3. Effect of Diabetes on Membrane Potential
Repolarization Rate
Condition Energization (mV) Repolarization (mV) (% of Mean Control) Lag Phase (s)
3 Weeks
Wistar 207.0 ± 1.86 (n = 6) 205.7 ± 1.84 (n = 6) 99.0 ± 6.98 (n = 6) 55.2 ± 3.37 (n = 6)
STZ 217.4 ± 1.78 (n = 6)∗∗,‡ 215.3 ± 1.76 (n = 6)∗∗∗,‡ 146.4 ± 6.00 (n = 6)∗∗∗,‡ 39.0 ± 4.35 (n = 6)∗
9 Weeks
Wistar 210.4 ± 2.10 (n = 6) 209.4 ± 2.51 (n = 6) 93.7 ± 6.98 (n = 6) 53.6 ± 6.01 (n = 6)
STZ 209.6 ± 0.86 (n = 6)¶¶ 206.3 ± 0.69 (n = 6)¶¶¶ 94.8 ± 6.02 (n = 6)¶ 52.7 ± 6.80 (n = 6)
3 Months
Wistar 209.0 ± 1.46 (n = 7) 205.3 ± 1.76 (n = 7) 105.0 ± 12.12 (n = 7) 56.3 ± 4.27 (n = 7)
GK 215.8 ± 2.32 (n = 7)∗ 213.1 ± 2.25 (n = 7)∗ 107.6 ± 13.45 (n = 7)†,¶ 46.3 ± 3.96 (n = 7)
6 Months
Wistar 207.1 ± 2.59 (n = 8) 205.8 ± 2.30 (n = 8) 101.4 ± 10.32 (n = 8) 55.9 ± 2.84 (n = 8)
GK 219.2 ± 1.25 (n = 8)∗∗∗ 218.6 ± 1.14 (n = 8)∗∗∗ 142.2 ± 20.17 (n = 8)∗∗ 42.9 ± 3.39 (n = 8)∗
Values are given as mean ± SEM of the number of independent experiments indicated, performed with at least three different mitochondrial preparations. The
membrane potential was measured after the addition of 5 mM succinate, as the respiratory substrate (“energization”) and after the phosphorylation of ADP 200
nmol ADP (“repolarization”), corresponding to the recovery of membrane potential. Repolarization rate was determined as the time required to the complete
phosphorylation of ADP added; data are presented as the ratio between the values obtained and the mean of nondiabetic rats repolarization rate. Lag phase reflects
the time required to phosphorylate the ADP added. In all experiments, the line basement was determined by addition of 10 ng/mL of valinomicin at the end of
experiments, in order to completely abolish membrane potential.
∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 compared to controls; † p < 0.05, compared to STZ (3 weeks); ‡ p < 0.05, compared to STZ (9 weeks); ¶ p < 0.05, ¶¶ p < 0.01,
¶¶¶ p < 0.001, compared to GK (6 months).
potential decrease due to the addition of ADP (data
not shown).
Evaluation of Enzymatic Activities
Studies of enzymatic activities of respiratory com-
plexes were performed in order to localize which respi-
ratory complexes are affected by diabetes. We observed
that NADH:Q oxidoreductase (Complex I) and succi-
nate cytochrome c reductase (Complexes II-III) activi-
ties were not affected in diabetic rats, when compared
to controls (Figure 1A and 1C). However, succinate de-
hydrogenase (Complex II) activity was significantly in-
creased in STZ-treated rats and in GK rats at the age of
6 months (Figure 1B). Moreover, cytochrome c oxidase
(Complex IV) is significantly augmented in diabetic
rats (Figure 1D), particularly in STZ-treated rats after 9
weeks of treatment and GK rats of 6 months. However,
their control groups also present a decreased activity,
suggesting that age also diminishes cytochrome c oxi-
dase activity.
Mitochondrial H+-ATPase activity (Figure 1E) and
repolarization rate (Table 3) were significantly en-
hanced in STZ-treated rats after 3 weeks of treatment
and in GK rats of 6 months, while lag phase decreased.
These results suggest that the phosphorylative system
is stimulated in these diabetic rats. However, we found
that STZ-treated rats after 9 weeks of treatment showed
a decreased activity of H+-ATPase and that this is rein-
forced by repolarization rate results.
Our results clearly suggest that diabetic rats present
some metabolic adjustments, in order to increase ATP
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(A) (B)
(C) (D)
(E)
FIGURE 1. Respiratory chain enzymatic activities. (A) NADH:Q oxidorreductase (Complex I), (B) succinate dehydrogenase (Complex II),
(C) succinate cytochrome c reductase (Complexes II-III), (D) cytochrome c oxidase (Complex IV), (E) F1-ATPase (Complex V); activities
were determined as described in Materials and Methods section. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 compared to controls;
&& p < 0.01 compared to GK (6 months); ## p < 0.01, ### p < 0.001, compared to STZ (9 weeks); c p < 0.05, compared to Wistar (3 months/
3 weeks).
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production and compensate the impairments promoted
by the high glucose levels typical of the disease.
DISCUSSION
In response to changes in physiological functions,
body energy requirements undergo modifications ei-
ther during development [20], or disease [21,22]. Sev-
eral studies have been carried out to evaluate the al-
terations in mitochondrial functions of diabetic rats
[19,23–27], particularly in STZ-treated rats. However,
the studies concerning STZ-treated rats have been per-
formed with animals of different strains (Sprague-
Dawley, Fisher 344, Long-Evans, Wistar) and, also,
diabetes was induced with different amounts of strep-
tozotocin. Moreover, these studies were performed at
least 8 weeks after the induction of diabetes. Addition-
ally, in some experiments, insulin is also administerted
to the animals.
To circumvent all these disparities, we compared
the possible alterations in the liver mitochondrial res-
piratory system, using two animal models of type 1 and
type 2 diabetes mellitus: STZ-induced and GK rats, re-
spectively. Moreover, we observed the adjustments to
diabetes at the onset of the disease (STZ-induced rats
3-weeks after the treatment and GK rats 3-months old)
and as diabetes progresses (STZ-induced rats 9 weeks
after the treatment and GK rats 6-months old). These
ages were selected for two main reasons: first, the age
of the animals from this two groups is similar and sec-
ondly, 9 weeks after the treatment with streptozotocin,
STZ-treated rats present serious disorders due to their
severe hyperglycaemias.
We observed that GK rats, particularly GK rats
6 months-old, presented an improved respiratory ac-
tivity, since RCR, ADP/O, membrane potential, and
FCCP-stimulated respiration ratios are enhanced, as
compared to non-diabetic rats, used as controls. When
examined in detail, we observed that, as pointed out by
some previous results [24,25], succinate dehydrogenase
activity was stimulated in GK rats with 6 months, while
no differences in respiratory complex II activity were
found in GK rats 3-months old. Moreover, we observed
that cytochrome c oxidase activity and H+-ATPase [19]
were also increased in diabetic GK rats and that these
metabolic adjustments were more evident in GK rats
with 6 months. No significant changes were found in
Complexes I and II-III. These results suggest that un-
til the age of 6 months, liver mitochondrial oxidative
phosphorylation is enhanced in this model of type 2
diabetes.
Since GK rats are important models to determine
initial metabolic events of diabetes, we can suggest
that stimulation of liver respiratory activity may be an
initial consequence of diabetes. Additionally, we ob-
served similar adjustments in STZ-treated rats, 3 weeks
after the induction of diabetes, reinforcing our previous
statement.
A decline in ATP generation affects glycolysis ratio,
decreasing glucose, fructose, and several aminoacids
utilization [8,9], leading to severe energetic impair-
ment. Therefore, improving respiratory activity in liver
mitochondria seems to be a metabolic adjustment to
circumvent injury in hepatocytes due to a decrease in
ATP synthesis. Moreover, (nuclear and) mtDNA tran-
scription is highly coupled to ATP levels [27]. It has also
been described that cytochrome c oxidase regulates res-
piratory rates and, therefore, energy metabolism [26],
and this regulation is linked to ATP/ADP ratios. Thus,
high ATP/ADP ratios decrease respiratory ratios and
m, due adenine nucleotide binding to cytochrome
c oxidase. We previously reported that liver mitochon-
dria from GK rats presented a decreased ATP/ADP ra-
tio and an GK rats presented an enlarged ADP content
than Wistar rats [24,25]. Moreover, we found that liver
mitochondrial ATP/ADP ratio was also significantly
decreased in GK rats with 2, 3, and 12 months, as com-
pared to respective controls [24,25]. Therefore, it seems
plausible that similar decreases in ATP/ADP ratio oc-
cur in STZ-treated rats (particularly, until 3 weeks after
streptozotocin administration), and the enhanced ac-
tivity of respiratory chain of diabetic rats (namely STZ-
induced rats 3 weeks after treatment and GK rats of 6
months) can be a consequence of these decreased ratios.
In STZ-treated rats 9 weeks after the induction
of diabetes, initial increase in respiratory parameters
ends up, owing to continuous severe hyperglycaemia.
Furthermore, initial increase in respiratory parameters
ends also, despite succinate dehydrogenase (Complex
II) and cytochrome c oxidase (Complex IV) specific ac-
tivities still being increased. The most affected compo-
nent of respiratory chain, undoubtedly is H+-ATPase,
and this inhibition is reflected in the respiratory ratio
(RCR). However, hepatocytes, as well as pancreatic -
cells, are exposed to elevated glucose concentrations,
being highly exposed to glucose injury (“glucose toxic-
ity”). Changes in membrane composition, particularly,
a reduction in fatty acids unsaturation index and de-
creased function of membranar enzymes have already
been described [23,28]. The decrease in uncoupled res-
piration, observed in STZ-induced rats 9 weeks after the
diabetogenic treatment, can therefore reflect an alter-
ation in respiratory complexes assembly due to mem-
brane variations, rather than a decrease of their specific
activity, while a decrease in H+-ATPase, in these exper-
imental conditions, can indicate an alteration between
FoF1-ATPsynthase and adenine nucleotide translocator
(ANT) coupling due to membranar alterations or a di-
rect inhibition at (one of) these components.
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Alterations in respiratory chain activity in non-
diabetic rats with age have also been found [29–31].
A slightly decrease in cytochrome c oxidase (complex
IV) and F1-ATPase (complex V) activities from 9 weeks
STZ-induced rat control group and GK rats of 6 months
control group was found, comparatively with younger
control groups. Moreover, RCR and ADP/O are slightly
decreased. These two groups of control animals have
similar ages (19 for 9 weeks STZ and 22 for GK rats
of 6 months; 14 weeks for 3 weeks STZ and GK of
3 months). Therefore, these results confirm that rat
liver mitochondria respiratory chain activity from non-
diabetic rats is decreased during age.
These results allow us to conclude that diabetic
rats present some metabolic adjustments, in order to
increase ATP production, to compensate for the impair-
ments promoted by the high glucose levels typical of the
disease. These adjustments are evident in GK rats with
6 months age and in STZ-treated rats 3 weeks after ad-
ministration of this diabetogenic drug, while GK rats
with 3 months age present an intermediate situation.
Conversely, phosphorylative and oxidative systems in
STZ-treated rats 9 weeks after the treatment show de-
creased activities, compared to their control group.
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